Clinical Trials Browser

Recurrence × Combined Modality Therapy × Plasma cell × Clear all

NCT01889420 2015-07-31

Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Phase 1 Terminated

1 enrolled 3 charts

Recurrence, Neoplasms, Plasma Cell